Slideshow
NIH Updates Testing, Treatment Guidelines During Co-circulation of Influenza and COVID-19
Author(s):
The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.
The National Institutes of Health (NIH) on October 22, 2020 made updates to its COVID-19 Treatment Guidelines that provide information for clinicians in communities where influenza viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are co-circulating.
Titled Influenza and COVID-19, the new section in the guideline discusses:
- Influenza vaccination for those with COVID-19
- Clinical presentation similarities/differences between the 2 viruses
- Potential for co-infection with influenza and SARS-CoV-2
- Testing for influenza and SARS-CoV-2 in patients with acute respiratory symptoms
- Treatment of influenza in the setting of co-circulatling SARS-CoV-2
Get a top-line review in the short slideshow that follows.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
